Mikel Asier Garro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mikel Asier Garro has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Ane Lazkano
Área de Enfermedades Sistémicas, Instituto de Investigación Biodonostia, San Sebastián, Guipúzcoa, Spain
2 shared publications- Angel Menargues
Research Department of S. A. Lasa Laboratories, c/. Laurea Miró, 385, Sant Feliu de Llobregat, Barcelona
2 shared publications - Antonio Miralles
University of the Balearic Islands
2 shared publications - J. Javier Meana
University of the Basque Country
2 shared publications Jesús A. García-Sevilla
2 shared publications- Joan Sallés
Department of Pharmacology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain
2 shared publications
Latest Publications
- Open Access
- 1 August 2019
- Published by Universitat Politecnica de Valencia
Mejora del rendimiento académico del alumnado de Farmacología mediante la utilización de metodologías activas y recursos on-line
La asignatura de Farmacología en el grado de Enfermería cubre necesidades de aprendizaje para la futura actividad profesional del personal de Enfermería tan importantes como la correcta administración de fármacos o la prevención de eventos adversos mediante el conocimiento de los mecanismos de acción y efectos adversos de los fármacos. El objetivo del presente trabajo es analizar el posible beneficio que la implantación de metodologías activas y recursos on-line así como cuestionarios Socrative® y el aula invertida tienen sobre la adquisición de dichas competencias por parte del alumnado de segundo curso del grado de Enfermería. Se han analizado tres cohortes con una implantación progresiva de dichas metodologías y recursos docentes. Los resultados demuestran una clara mejoría en el rendimiento académico del alumnado en todas las competencias analizadas con un coste-beneficio en cuanto a esfuerzo del alumnado y mejora en el rendimiento académico asumible.
- 1 August 2019
- Published by Universitat Politecnica de Valencia
Open AccessMejora del rendimiento académico del alumnado de Farmacología mediante la utilización de metodologías activas y recursos on-line
La asignatura de Farmacología en el grado de Enfermería cubre necesidades de aprendizaje para la futura actividad profesional del personal de Enfermería tan importantes como la correcta administración de fármacos o la prevención de eventos adversos mediante el conocimiento de los mecanismos de acción y efectos adversos de los fármacos. El objetivo del presente trabajo es analizar el posible beneficio que la implantación de metodologías activas y recursos on-line así como cuestionarios Socrative® y el aula invertida tienen sobre la adquisición de dichas competencias por parte del alumnado de segundo curso del grado de Enfermería. Se han analizado tres cohortes con una implantación progresiva de dichas metodologías y recursos docentes. Los resultados demuestran una clara mejoría en el rendimiento académico del alumnado en todas las competencias analizadas con un coste-beneficio en cuanto a esfuerzo del alumnado y mejora en el rendimiento académico asumible.
- 1 October 2017
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 70 (10) , 832-840
Papel del colágeno miocárdico en la estenosis aórtica grave con fracción de eyección conservada y síntomas de insuficiencia cardiaca
- 1 October 2017
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 70 (10) , 832-840
Papel del colágeno miocárdico en la estenosis aórtica grave con fracción de eyección conservada y síntomas de insuficiencia cardiaca
- 24 October 2009
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 337 (1-2) , 167-173
Phospholipase Cβ4 isozyme is expressed in human, rat, and murine heart left ventricles and in HL-1 cardiomyocytes
Phospholipase C-β (PLCβ) isozymes (PLCβ1 and PLCβ3) have been extensively characterized in cardiac tissue, but no data are available for the PLCβ4 isozyme. In this study, PLCβ(1–4) isozymes mRNA relative expression was studied by real-time PCR (RT-PCR) in human, rat, and murine left ventricle and the presence of PLCβ4 isozyme at the protein level was confirmed by Western blotting in all species studied. Confocal microscopy experiments carried out in HL-1 cardiomyocytes revealed a sarcoplasmic subcellular distribution of PLCβ4. Although there were unexpected significant interspecies differences in the PLCβ(1–4) mRNA expression, PLCβ4 mRNA was the main transcript expressed in all left ventricles studied. Thus, whereas in human and rat left ventricles PLCβ4 > PLCβ3 > PLCβ2 > PLCβ1 mRNA pattern of expression was found, in murine left ventricle the pattern of expression was different, i.e., PLCβ4 > PLCβ1 > PLCβ3 > PLCβ2. However, results obtained in mouse HL-1 cardiomyocytes showed PLCβ3 ≈ PLCβ4 > PLCβ1 > PLCβ2 pattern of mRNA expression indicating a probable cell type specific expression of the different PLCβ isozymes in cardiomyocytes. Finally, RT-PCR experiments showed a trend, even though not significant (P = 0.067), to increase PLCβ4 mRNA levels in HL-1 cardiomyocytes after angiotensin II treatment. These results demonstrate the presence of PLCβ4 in the heart and in HL-1 cardiomyocytes showing a different species-dependent pattern of expression of the PLCβ(1–4) transcripts. We discuss the relevance of these findings in relation to the development of cardiac hypertrophy.
- 24 October 2009
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 337 (1-2) , 167-173
Phospholipase Cβ4 isozyme is expressed in human, rat, and murine heart left ventricles and in HL-1 cardiomyocytes
Phospholipase C-β (PLCβ) isozymes (PLCβ1 and PLCβ3) have been extensively characterized in cardiac tissue, but no data are available for the PLCβ4 isozyme. In this study, PLCβ(1–4) isozymes mRNA relative expression was studied by real-time PCR (RT-PCR) in human, rat, and murine left ventricle and the presence of PLCβ4 isozyme at the protein level was confirmed by Western blotting in all species studied. Confocal microscopy experiments carried out in HL-1 cardiomyocytes revealed a sarcoplasmic subcellular distribution of PLCβ4. Although there were unexpected significant interspecies differences in the PLCβ(1–4) mRNA expression, PLCβ4 mRNA was the main transcript expressed in all left ventricles studied. Thus, whereas in human and rat left ventricles PLCβ4 > PLCβ3 > PLCβ2 > PLCβ1 mRNA pattern of expression was found, in murine left ventricle the pattern of expression was different, i.e., PLCβ4 > PLCβ1 > PLCβ3 > PLCβ2. However, results obtained in mouse HL-1 cardiomyocytes showed PLCβ3 ≈ PLCβ4 > PLCβ1 > PLCβ2 pattern of mRNA expression indicating a probable cell type specific expression of the different PLCβ isozymes in cardiomyocytes. Finally, RT-PCR experiments showed a trend, even though not significant (P = 0.067), to increase PLCβ4 mRNA levels in HL-1 cardiomyocytes after angiotensin II treatment. These results demonstrate the presence of PLCβ4 in the heart and in HL-1 cardiomyocytes showing a different species-dependent pattern of expression of the PLCβ(1–4) transcripts. We discuss the relevance of these findings in relation to the development of cardiac hypertrophy.
- 1 July 2004
- Published by Springer Nature in Neurochemical Research
- Vol. 29 (7) , 1461-1465
Differential Postmortem Delay Effect on Agonist-Mediated Phospholipase Cβ Activity in Human Cortical Crude and Synaptosomal Brain Membranes
The phosphoinositide signal transduction system, and particularly, phospholipase Cβ isozymes, are relevant in the etiopathogeny of human neuropsychiatric pathologies such as depression. Stimulation of phospholipase Cβ activity by muscarinic receptors and G proteins was determined in crude and synaptosomal membrane preparations from nine postmortem human frontal cortices (postmortem delay range 8 to 50 h). Thus, the phospholipase Cβ activity was determined by measuring the hydrolysis of exogenous [3H]-phosphatidylinositol 4,5-bisphosphate. There was a postmortem delay-mediated decrease in the PIP2 hydrolysis irrespective of the membrane preparation used (P < 0.05). Moreover, there were statistically significant differences for exponential decay curve parameters (K factor and Span) of PLCβ activity induced by agonist-mediated activation between crude and synaptosomal membrane preparations. These results show that the postsynaptic component of the PLCβ activity is more sensible to the postmortem delay effect.
- 1 July 2004
- Published by Springer Nature in Neurochemical Research
- Vol. 29 (7) , 1461-1465
Differential Postmortem Delay Effect on Agonist-Mediated Phospholipase Cβ Activity in Human Cortical Crude and Synaptosomal Brain Membranes
The phosphoinositide signal transduction system, and particularly, phospholipase Cβ isozymes, are relevant in the etiopathogeny of human neuropsychiatric pathologies such as depression. Stimulation of phospholipase Cβ activity by muscarinic receptors and G proteins was determined in crude and synaptosomal membrane preparations from nine postmortem human frontal cortices (postmortem delay range 8 to 50 h). Thus, the phospholipase Cβ activity was determined by measuring the hydrolysis of exogenous [3H]-phosphatidylinositol 4,5-bisphosphate. There was a postmortem delay-mediated decrease in the PIP2 hydrolysis irrespective of the membrane preparation used (P < 0.05). Moreover, there were statistically significant differences for exponential decay curve parameters (K factor and Span) of PLCβ activity induced by agonist-mediated activation between crude and synaptosomal membrane preparations. These results show that the postsynaptic component of the PLCβ activity is more sensible to the postmortem delay effect.
- 22 April 2004
- Published by Wiley in Journal of Neurochemistry
- Vol. 89 (6) , 1537-1546
NMDA‐receptor regulation of muscarinic‐receptor stimulated inositol 1,4,5‐trisphosphate production and protein kinase C activation in single cerebellar granule neurons
Inositol 1,4,5‐trisphosphate (InsP3) production in single cerebellar granule neurons (CGNs) grown in culture was measured using the PH domain of phospholipase C δ1 tagged with enhanced green fluorescent protein (eGFP‐PHPLCδ1). These measurements were correlated with changes in intracellular free Ca2+ determined by single cell imaging. In control CGNs, intracellular Ca2+ stores appeared replete. However, the refilling state of these stores appeared dependent on the fluorophore used to measure Ca2+‐release. Thus, methacholine (MCH), acting via muscarinic acetylcholine‐receptors (mAchRs), mobilised intracellular Ca2+ in cells loaded with fluo‐3 and fura‐4f, but not fura‐2. Confocal measurements of single CGNs expressing eGFP‐PHPLCδ1 demonstrated that MCH stimulated a robust peak increase in InsP3, which was followed by a sustained plateau phase of InsP3 production. In contrast, glutamate‐induced InsP3 signals were weak or not detectable. MCH‐stimulated InsP3 production was reduced by chelation of intracellular Ca2+ with BAPTA, and emptying of intracellular stores with thapsigargin, indicated a positive feedback effect of Ca2+ mobilisation onto PLC activity. In CGNs, NMDA‐ and KCl‐mediated Ca2+‐entry significantly enhanced MCH‐induced InsP3 production. Furthermore, mAchR‐mediated PLC activation appeared sensitive to the full dynamic range of intracellular Ca2+ increases stimulated by 100 μm NMDA. This dynamic regulation was also observed at the level of PKC activation indicated by an enhanced translocation of eGFP‐tagged myristoylated alanine‐rich C kinase substrate (MARCKS) protein in cells stimulated with MCH. Thus, NMDA‐mediated Ca2+ influx and PLC activation may represent a coincident‐detection system whereby ionotropic and metabotropic signals combine to stimulate InsP3 production and PKC‐mediated phosphorylation events in CGNs.
- 22 April 2004
- Published by Wiley in Journal of Neurochemistry
- Vol. 89 (6) , 1537-1546
NMDA‐receptor regulation of muscarinic‐receptor stimulated inositol 1,4,5‐trisphosphate production and protein kinase C activation in single cerebellar granule neurons
Inositol 1,4,5‐trisphosphate (InsP3) production in single cerebellar granule neurons (CGNs) grown in culture was measured using the PH domain of phospholipase C δ1 tagged with enhanced green fluorescent protein (eGFP‐PHPLCδ1). These measurements were correlated with changes in intracellular free Ca2+ determined by single cell imaging. In control CGNs, intracellular Ca2+ stores appeared replete. However, the refilling state of these stores appeared dependent on the fluorophore used to measure Ca2+‐release. Thus, methacholine (MCH), acting via muscarinic acetylcholine‐receptors (mAchRs), mobilised intracellular Ca2+ in cells loaded with fluo‐3 and fura‐4f, but not fura‐2. Confocal measurements of single CGNs expressing eGFP‐PHPLCδ1 demonstrated that MCH stimulated a robust peak increase in InsP3, which was followed by a sustained plateau phase of InsP3 production. In contrast, glutamate‐induced InsP3 signals were weak or not detectable. MCH‐stimulated InsP3 production was reduced by chelation of intracellular Ca2+ with BAPTA, and emptying of intracellular stores with thapsigargin, indicated a positive feedback effect of Ca2+ mobilisation onto PLC activity. In CGNs, NMDA‐ and KCl‐mediated Ca2+‐entry significantly enhanced MCH‐induced InsP3 production. Furthermore, mAchR‐mediated PLC activation appeared sensitive to the full dynamic range of intracellular Ca2+ increases stimulated by 100 μm NMDA. This dynamic regulation was also observed at the level of PKC activation indicated by an enhanced translocation of eGFP‐tagged myristoylated alanine‐rich C kinase substrate (MARCKS) protein in cells stimulated with MCH. Thus, NMDA‐mediated Ca2+ influx and PLC activation may represent a coincident‐detection system whereby ionotropic and metabotropic signals combine to stimulate InsP3 production and PKC‐mediated phosphorylation events in CGNs.
- 1 April 2001
- Published by Elsevier in Neuropharmacology
- Vol. 40 (5) , 686-695
Regulation of phospholipase Cβ activity by muscarinic acetylcholine and 5-HT2 receptors in crude and synaptosomal membranes from human cerebral cortex
- 1 April 2001
- Published by Elsevier in Neuropharmacology
- Vol. 40 (5) , 686-695
Regulation of phospholipase Cβ activity by muscarinic acetylcholine and 5-HT2 receptors in crude and synaptosomal membranes from human cerebral cortex
- Open Access
- 1 October 1999
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 85 (4) , 74-79
Pilocarpine Treatments Differentially Affect α2‐Adrenoceptors which Modulate the Firing Rate of Locus coeruleus Neurones and the Synthesis and Release of Noradrenaline in Rat Brain
We have investigated the effect of treatments with the muscarinic acetylcholine receptor agonist, pilocarpine, on the sensitivity of central α2‐adrenoceptors that regulate the firing activity of rat locus coeruleus, the tyrosine hydroxylase activity in the rat cortex, hippocampus and hypothalamus, and the K+‐evoked release of [3H]noradrenaline from rat cortical and hippocampal synaptosomes. Short‐term (4 days), but not acute, treatment with pilocarpine caused a small but statistically significant increase in the inhibitory effect of the α2‐adrenoceptor agonist clonidine on the firing rate of locus coeruleus neurones, with a decrease in the ED50of 29% (P2‐adrenoceptor antagonist idazoxan. Moreover, treatments (4, 11 and 19 days) with pilocarpine did not alter the inhibitory effect of clonidine [10−8‐10−5M] on the K+‐evoked release of [3H]noradrenaline from rat cortical and hippocampal synaptosomes. These results indicate that administration of pilocarpine slightly potentiates some but not all the functional responses mediated by brain presynaptic α2‐adrenoceptors. In conclusion, these results do not support the hypothesis that chronic treatments with pilocarpine lead to a suitable model of α2‐adrenoceptor supersensitivity.
- 1 October 1999
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 85 (4) , 74-79
Open AccessPilocarpine Treatments Differentially Affect α2‐Adrenoceptors which Modulate the Firing Rate of Locus coeruleus Neurones and the Synthesis and Release of Noradrenaline in Rat Brain
We have investigated the effect of treatments with the muscarinic acetylcholine receptor agonist, pilocarpine, on the sensitivity of central α2‐adrenoceptors that regulate the firing activity of rat locus coeruleus, the tyrosine hydroxylase activity in the rat cortex, hippocampus and hypothalamus, and the K+‐evoked release of [3H]noradrenaline from rat cortical and hippocampal synaptosomes. Short‐term (4 days), but not acute, treatment with pilocarpine caused a small but statistically significant increase in the inhibitory effect of the α2‐adrenoceptor agonist clonidine on the firing rate of locus coeruleus neurones, with a decrease in the ED50of 29% (P2‐adrenoceptor antagonist idazoxan. Moreover, treatments (4, 11 and 19 days) with pilocarpine did not alter the inhibitory effect of clonidine [10−8‐10−5M] on the K+‐evoked release of [3H]noradrenaline from rat cortical and hippocampal synaptosomes. These results indicate that administration of pilocarpine slightly potentiates some but not all the functional responses mediated by brain presynaptic α2‐adrenoceptors. In conclusion, these results do not support the hypothesis that chronic treatments with pilocarpine lead to a suitable model of α2‐adrenoceptor supersensitivity.
- 1 August 1993
- Published by Elsevier in European Journal of Pharmacology
- Vol. 239 (1-3) , 149-157
Acute and chronic effects of reserpine on biochemical and functional parameters of central and peripheral α2-adrenoceptors
- 1 August 1993
- Published by Elsevier in European Journal of Pharmacology
- Vol. 239 (1-3) , 149-157
Acute and chronic effects of reserpine on biochemical and functional parameters of central and peripheral α2-adrenoceptors
- 1 June 1993
- Published by Elsevier in European Journal of Pharmacology
- Vol. 236 (3) , 467-476
Acute and chronic effects of cholinesterase inhibitors and pilocarpine on the density and sensitivity of central and peripheral α2-adrenoceptors
- 1 June 1993
- Published by Elsevier in European Journal of Pharmacology
- Vol. 236 (3) , 467-476
Acute and chronic effects of cholinesterase inhibitors and pilocarpine on the density and sensitivity of central and peripheral α2-adrenoceptors
- 1 May 1992
- Published by Wiley in Journal of Neurochemistry
- Vol. 58 (5) , 1896-1904
Decreased Density of Presynaptic α2‐Adrenoceptors in Postmortem Brains of Patients with Alzheimer's Disease
The full agonist [3H]bromoxidine (UK 14304) was used to quantitate α2‐adrenoceptors in postmortem brains of patients with Alzheimer's disease. The effects of aging and human serum Cohn fraction IV on [3H]bromoxidine binding were also assessed. In patients with Alzheimer's disease, the binding capacity (Bmax) of [3H]bromoxidine was lower in the frontal cortex (37%), hypothalamus (33%), and cerebellum (52%) than in matched controls. In the hippocampus, amygdala, and head of caudate, the binding capacities (Bmax) were unchanged. Quantitative autoradiographic analyses with [3H]bromoxidine confirmed the existence of a marked reduction (55–60%) in α2A‐adrenoceptor density in the frontal cortex (layers I and III). In patients with dementia who did not meet neuropathological criteria for Alzheimer's disease, the density of α2‐adrenoceptors was unchanged. In control subjects, the density of α2A‐adrenoceptors in the frontal cortex showed a significant negative correlation with age at death. The inhibitory effect of human serum Cohn fraction IV on [3H]bromoxidine was very similar in control subjects and patients with Alzheimer's disease. The observed decrease in the density of brain α2‐adrenoceptors in Alzheimer's disease may represent direct biochemical evidence of a presynaptic location of this receptor on noradrenergic nerve terminals in the human CNS.
- 1 May 1992
- Published by Wiley in Journal of Neurochemistry
- Vol. 58 (5) , 1896-1904
Decreased Density of Presynaptic α2‐Adrenoceptors in Postmortem Brains of Patients with Alzheimer's Disease
The full agonist [3H]bromoxidine (UK 14304) was used to quantitate α2‐adrenoceptors in postmortem brains of patients with Alzheimer's disease. The effects of aging and human serum Cohn fraction IV on [3H]bromoxidine binding were also assessed. In patients with Alzheimer's disease, the binding capacity (Bmax) of [3H]bromoxidine was lower in the frontal cortex (37%), hypothalamus (33%), and cerebellum (52%) than in matched controls. In the hippocampus, amygdala, and head of caudate, the binding capacities (Bmax) were unchanged. Quantitative autoradiographic analyses with [3H]bromoxidine confirmed the existence of a marked reduction (55–60%) in α2A‐adrenoceptor density in the frontal cortex (layers I and III). In patients with dementia who did not meet neuropathological criteria for Alzheimer's disease, the density of α2‐adrenoceptors was unchanged. In control subjects, the density of α2A‐adrenoceptors in the frontal cortex showed a significant negative correlation with age at death. The inhibitory effect of human serum Cohn fraction IV on [3H]bromoxidine was very similar in control subjects and patients with Alzheimer's disease. The observed decrease in the density of brain α2‐adrenoceptors in Alzheimer's disease may represent direct biochemical evidence of a presynaptic location of this receptor on noradrenergic nerve terminals in the human CNS.